Ehave is a leading healthcare services and technology company, focused on progressing Psychedelics-to-Therapeutics by engineering novel compounds and new treatment protocols for treating brain health.
Together with our network of scientists and mental health professionals, we are on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues, leveraging clinical data to help us achieve optimal patient outcomes.
Ehave’s operations span across the entire USA, Canada, Jamaica, and Australia.
Redefining The Way We Heal
Our mission is to create safe and effective therapeuatics that will help achieve better patient outcomes when dealing with brain health issues such as depression, anxiety, and PTSD.
Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. Our Dashboard is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. Through our technology we offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it's a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.